BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38032013)

  • 1. High-intensity focused ultrasound ablation combined with systemic therapy for unresectable colorectal cancer liver metastasis: A propensity score-matched analysis.
    Tang F; Zhong Q; Ni T; Xue Y; Wu J; Deng R; Zhang Q; Li Y; He X; Yang Z; Zhang Y
    Cancer Med; 2023 Dec; 12(24):21985-21995. PubMed ID: 38032013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Intensity Focused Ultrasound Ablation for Patients With Locally Advanced Pancreatic Adenocarcinoma: A Propensity Score-Matching Analysis.
    Ning J; Wang S; Guo Y; Diao J; Bai X; Wang H; Hu K; Zhao Q
    J Ultrasound Med; 2023 Jul; 42(7):1595-1607. PubMed ID: 36691925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIFU for the treatment of difficult colorectal liver metastases with unsuitable indications for resection and radiofrequency ablation: a phase I clinical trial.
    Yang T; Ng DM; Du N; He N; Dai X; Chen P; Wu F; Chen B; Fan X; Yan K; Zhou X; Dong M; Zheng Z; Gu L
    Surg Endosc; 2021 May; 35(5):2306-2315. PubMed ID: 32435962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective analysis of survival factors of high intensity focused ultrasound (HIFU) treatment for unresectable pancreatic cancer.
    Ning ZY; Cheng CS; Xie J; Chen QW; Xu LT; Zhuang LP; Zhang CY; Song LB; Shi WD; Zhu XY; Wang P; Wang K; Meng ZQ
    Discov Med; 2016 Jun; 21(118):435-45. PubMed ID: 27448780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of ultrasound-guided high-intensity focused ultrasound ablation for the treatment of colorectal cancer liver metastases.
    Yang T; Chen Q; Kuang L; Fu Z; Wang Y; Chen Y; Yang L; Xu Y
    Int J Hyperthermia; 2022; 39(1):829-834. PubMed ID: 35732289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-intensity focused ultrasound: noninvasive treatment for local unresectable recurrence of osteosarcoma.
    Yu W; Tang L; Lin F; Yao Y; Shen Z; Zhou X
    Surg Oncol; 2015 Mar; 24(1):9-15. PubMed ID: 25453577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage high intensity focused ultrasound for residual or recurrent cervical cancer after definitive chemoradiotherapy.
    Zhong Q; Tang F; Ni T; Chen Y; Liu Y; Wu J; Zhou W; Feng Z; Lu X; Tan S; Zhang Y
    Front Immunol; 2022; 13():995930. PubMed ID: 36325337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Therapy.
    Sofuni A; Asai Y; Tsuchiya T; Ishii K; Tanaka R; Tonozuka R; Honjo M; Mukai S; Nagai K; Yamamoto K; Matsunami Y; Kurosawa T; Kojima H; Homma T; Minami H; Nakatsubo R; Hirakawa N; Miyazawa H; Nagakawa Y; Tsuchida A; Itoi T
    Curr Oncol; 2021 Nov; 28(6):4845-4861. PubMed ID: 34898585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.
    Cheung TT; Poon RT; Jenkins CR; Chu FS; Chok KS; Chan AC; Tsang SH; Dai WC; Yau TC; Chan SC; Fan ST; Lo CM
    Liver Int; 2014 Jul; 34(6):e136-43. PubMed ID: 24451026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: comparison with transarterial chemoembolisation monotherapy--preliminary observations.
    Kim J; Chung DJ; Jung SE; Cho SH; Hahn ST; Lee JM
    Br J Radiol; 2012 Oct; 85(1018):e940-6. PubMed ID: 22553305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIFU for the treatment of gastric cancer with liver metastases with unsuitable indications for hepatectomy and radiofrequency ablation: a prospective and propensity score-matched study.
    Zhou B; He N; Hong J; Yang T; Ng DM; Gao X; Yan K; Fan X; Zheng Z; Chen P; Zheng J; Zheng Q
    BMC Surg; 2021 Jul; 21(1):308. PubMed ID: 34253213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of high-intensity focused ultrasound-assisted hepatic resection (HIFU-AR) on blood loss reduction in patients with liver metastases requiring hepatectomy: study protocol for a randomized controlled trial.
    Dupré A; Pérol D; Blanc E; Peyrat P; Basso V; Chen Y; Vincenot J; Kocot A; Melodelima D; Rivoire M
    Trials; 2017 Feb; 18(1):57. PubMed ID: 28166812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis.
    Sugimoto K; Sakamoto K; Ii Y; Amemiya K; Sugo H; Ito T; Munakata S; Takahashi M; Kojima Y; Tomiki Y; Sato K; Saiura A; Kawasaki S
    BMC Surg; 2021 Apr; 21(1):188. PubMed ID: 33836701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation.
    Chok KS; Cheung TT; Lo RC; Chu FS; Tsang SH; Chan AC; Sharr WW; Fung JY; Dai WC; Chan SC; Fan ST; Lo CM
    Liver Transpl; 2014 Aug; 20(8):912-21. PubMed ID: 24753206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes Following Different Thermal Ablation Strategies in Patients with Unresectable Colorectal Liver Metastases.
    Li J; Liu G; Xie X; Zhang D; Zheng R; Yang H; Zhong H; Dai G; Yu J; Liang P
    Radiology; 2023 Aug; 308(2):e223135. PubMed ID: 37581502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity.
    Marinova M; Rauch M; Mücke M; Rolke R; Gonzalez-Carmona MA; Henseler J; Cuhls H; Radbruch L; Strassburg CP; Zhang L; Schild HH; Strunk HM
    Eur Radiol; 2016 Nov; 26(11):4047-4056. PubMed ID: 26886904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of Sonazoid in Assisting High-Intensity Focused Ultrasound Ablation Therapy for Advanced Liver Malignant Lesions: A Single-Arm Clinical Study.
    Zhou H; Li F; Luo L; Xiong X; Zhou K; Zhu H; Zhang J; Li P
    Ultrasound Med Biol; 2024 Jan; 50(1):134-141. PubMed ID: 37865612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-intensity focused ultrasound combined with hysteroscopic resection for the treatment of placenta accreta.
    Ye M; Yin Z; Xue M; Deng X
    BJOG; 2017 Aug; 124 Suppl 3():71-77. PubMed ID: 28856861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can pre- and postoperative magnetic resonance imaging predict recurrence-free survival after whole-gland high-intensity focused ablation for prostate cancer?
    Rosset R; Bratan F; Crouzet S; Tonoli-Catez H; Mège-Lechevallier F; Gelet A; Rouvière O
    Eur Radiol; 2017 Apr; 27(4):1768-1775. PubMed ID: 27436018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.